TE

Tema ETFs Portfolio holdings

AUM $377M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$93.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
174
New
Increased
Reduced
Closed

Top Buys

1
+$5.48M
2
+$4.98M
3
+$4.58M
4
TKR icon
Timken Company
TKR
+$4.49M
5
LLY icon
Eli Lilly
LLY
+$4.13M

Top Sells

1
+$7.13M
2
+$5.32M
3
+$5.11M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.66M
5
ASND icon
Ascendis Pharma
ASND
+$2.02M

Sector Composition

1 Industrials 43.38%
2 Healthcare 33.02%
3 Utilities 7.31%
4 Technology 5.91%
5 Financials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALEC icon
151
Alector
ALEC
$308M
– –
-14,344
BNTX icon
152
BioNTech
BNTX
$25.3B
– –
-4,500
CLDX icon
153
Celldex Therapeutics
CLDX
$1.78B
– –
-29,480
EFX icon
154
Equifax
EFX
$28B
– –
-2,354
EME icon
155
Emcor
EME
$30.8B
– –
-952
EXAS icon
156
Exact Sciences
EXAS
$11.6B
– –
-15,008
FLR icon
157
Fluor
FLR
$7.54B
– –
-107,800
FSS icon
158
Federal Signal
FSS
$7.32B
– –
-55,272
JSPR icon
159
Jasper Therapeutics
JSPR
$68.4M
– –
-12,435
KROS icon
160
Keros Therapeutics
KROS
$421M
– –
-35,663
MLYS icon
161
Mineralys Therapeutics
MLYS
$3.38B
– –
-89,529
MRNA icon
162
Moderna
MRNA
$10.2B
– –
-9,475
PRIM icon
163
Primoris Services
PRIM
$7.39B
– –
-93,374
SLNO icon
164
Soleno Therapeutics
SLNO
$3.48B
– –
-13,178
SMR icon
165
NuScale Power
SMR
$5.92B
– –
-15,456
SRPT icon
166
Sarepta Therapeutics
SRPT
$2.36B
– –
-1,943
SRRK icon
167
Scholar Rock
SRRK
$2.69B
– –
-4,836
SWTX
168
DELISTED
SpringWorks Therapeutics
SWTX
– –
-30,811
TERN icon
169
Terns Pharmaceuticals
TERN
$736M
– –
-79,696
TYL icon
170
Tyler Technologies
TYL
$21.9B
– –
-408
UNP icon
171
Union Pacific
UNP
$134B
– –
-7,413
VERV
172
DELISTED
Verve Therapeutics
VERV
– –
-89,239
ITCI
173
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-3,388
NARI
174
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-14,790
3 4 5 6
7